Breaking News
Get 45% Off 0
🤖 Are you in? These 5 AI-picked stocks are up 15%+
Read article

Stock Markets Analysis & Opinion

Contribute
Steve Miller
BIDU Pops on Earnings But Faces Cyclical Headwinds By Steve Miller - Feb 14, 2018

Baidu Inc (NASDAQ:BIDU) reported earnings of $2.29 per share and revenue of $3.6 billion, which beat expectations of $2.05 per share and $3.4 billion. Analysts from Daiwa Capital and Wells Fargo...

Guy S. Ortmann, CMT
Near-Term Outlook Remains Neutral   By Guy S. Ortmann, CMT - Feb 14, 2018

Data MixedOpinionAll of the indexes closed higher yesterday with positive internals on the NYSE and NASDAQ as volumes declined from the prior session. One chart saw a minor technical improvement as...

Edison
ReNeuron Group: Consolidation Confusion?   By Edison - Feb 14, 2018

ReNeuron Group's (LON:RQE) recent 100 for 1 share consolidation was a benign and cosmetic ‘tidy up’ of its historical capital structure. The share price of ReNeuron is trading at 52-week...

Emilio Tomasini
Nasdaq 100: 2 Oversimplified Reasons For A Bull Ride By Emilio Tomasini - Feb 14, 2018

Sometimes markets talk to us and our job is only to listen without adding any degree of complexity. In the current market condition if we keep our analysis at the easiest level, that is at that level...

Zacks Investment Research
Real Estate ETF (REZ) Hits A New 52-Week Low By Zacks Investment Research - Feb 14, 2018

Investors looking to avoid underperformance should steer clear of iShares Residential Real Estate ETF (AX:REZ) . The fund recently hit a new 52-week low. Shares of REZ are down roughly 18.4% from its...

Zacks Investment Research
Why Defensive ETFs Fail In The Market Downturn? By Zacks Investment Research - Feb 14, 2018

U.S. economy has been on a rally since Donald Trump’s election victory. Trump’s tax reform was recently signed into law, increasing optimism among investors around a faster pace in...

Zacks Investment Research
Can Tech ETFs Regain Investors' Love After Selloff Snub? By Zacks Investment Research - Feb 14, 2018

The U.S. stock market has steadied from one of the largest routs seen since Trump win. Not only did several products fall out of investors’ favor, massive withdrawals were noticed in the biggest...

Paban Pandey
Small-Cap Stocks Diverge From Small-Business Optimism By Paban Pandey - Feb 14, 2018

Small-business optimism remains near multi-decade highs. Small-cap stocks do not quite share this optimism.The NFIB optimism index rose two points month-over-month in January to 106.9, just a...

Zacks Investment Research
Marriott (MAR) Tops Q4 Earnings & Sales Projections By Zacks Investment Research - Feb 14, 2018

Marriott International, Inc. (MAR) just released its fourth-quarter and full year 2017 financial results, posting adjusted earnings of $1.12 per share and revenues of $5.88 billion. Currently,...

Zacks Investment Research
Roche's Rituxan Gets Priority Review For Label Expansion By Zacks Investment Research - Feb 14, 2018

Roche Group’s (OTC:RHHBY) member Genentech announced that the FDA accepted Supplemental Biologics License Application (sBLA) and granted Priority Review for the label expansion of the...

Zacks Investment Research
AVEO (AVEO) To Get $2 Million From EUSA Pharma For Fotivda By Zacks Investment Research - Feb 14, 2018

AVEO Oncology (NASDAQ:AVEO) is due to receive $2 million from its partner EUSA Pharmaas the latter has been granted positive NICE recommendationfor Fotivda (tivozanib) for the first line treatment...

FxGrow
S&P, Dow, Nasdaq, And Russell Technical Summary By FxGrow - Feb 14, 2018

MAR MINI S&P 500 Closing price: (2663.50) Target price: None at the moment Resistance: 2685.00, 2700.00+ Support: 2626.00, 2590.00?, 2584.00* Trend: Down / daily Trend reversal price: 2745.00 /...

Continue with Apple
Continue with Google
or
Sign up with Email